-
Akkina R K, Walton R M, Chen M L. High-efficiency gene transfer into CD34+ cells with a human immunodeficiency virus type 1-based retroviral vector pseudotyped with vesicular stomatitis virus envelope glycoprotein G[J]. J Virol, 1996, 70(): 2581-2585.
-
An D S, Morizono K, Li Q. An inducible human immunodeficiency virus type 1 (HIV-1) vector which effectively suppresses HIV-1 replication[J]. J Virol, 1999, 73(): 7671-7677.
-
Anderson W F. Human gene therapy[J]. Nature, 1998, 392(): 25-30. doi: 10.1038/32058
-
Buchschacher G L, Wong-stall F. Development of lentiviral vectors for gene therapy for human diseases[J]. Blood, 2000, 95(): 2499-2504.
-
Bukovsky A A, Song J P, Naldini L. Interaction of human immunodeficiency virus-derived vectors with wild-type virus in transduced cells[J]. J Virol, 1999, 73(): 7087-7092.
-
Burns J C, Friedmann T, Driever W. Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells[J]. Proc Natl Acad Sci USA, 1993, 90(): 8033-8037. doi: 10.1073/pnas.90.17.8033
-
Cai K, Sham M K, Tam P. Lung cancer gene therapy[J]. Gene Ther Mol Biol, 2003, 7(): 255-272.
-
Cavazzana-Calvo M, Hacein-Bey S, de Saint Basile G. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease[J]. Science, 2000, 288(): 669-672. doi: 10.1126/science.288.5466.669
-
Chang L, Urlacher V, Iwakuma T. Efficacy and safety analyses of a recombinant human immunodeficiency virus 1 derived vector system[J]. Gene Ther, 1999, 6(): 715-728. doi: 10.1038/sj.gt.3300895
-
Coleman J E, Huentelman M J, Kasparov S. Efficient large-scale production and concentration of HIV-1-based lentiviral vectors for use in vivo[J]. Physiol Genomics, 2003, 12(): 221-228. doi: 10.1152/physiolgenomics.00135.2002
-
Corbeau P, Wong-staal F. Anti-HIV effects of HIV vectors[J]. Virology, 1996, 243(): 268-274.
-
Costantini L C, Bakowska J C, Breakefield X O. Gene therapy in the CNS[J]. Gene Ther, 2000, 7(): 93-109. doi: 10.1038/sj.gt.3301119
-
Costello E, Munoz M, Buetti E. Gene transfer into stimulated and unstimulated T lymphocytes by HIV-1-derived lentiviral vectors[J]. Gene Ther, 2002, 7(): 596-604.
-
Deola S, Scaramuzza S, Birolo R S. Mobilized blood CD34+ cells transduced and selected with a clinically applicable protocol reconstitute lymphopoiesis in SCID-hu mice[J]. Hum Gene Ther, 2004, 15(): 305-311. doi: 10.1089/104303404322886156
-
Dropulic B, Hermankova M, Pitha P A. A conditionally replicating HIV-1 vector interferes with wild-type HIV-1 replication and spread[J]. Proc Natl Acad Sci USA, 1996, 93(): 11103-11108. doi: 10.1073/pnas.93.20.11103
-
Emi N, Friedmann T, Yee J K. Pseudotype formation of murine leukemia virus with the G protein of vesicular stomatitis virus[J]. J Virol, 1991, 65(): 1202-1207.
-
Escarpe P, Zayek N, Chin P. Development of a sensitive assay for detection of replication-competent recombinant lentivirus in large-scale HIV-based vector preparation[J]. Mol Ther, 2003, 8(): 332-341. doi: 10.1016/S1525-0016(03)00167-9
-
Federico M. Lentiviruses as gene delivery vectors[J]. Curr Opin Biotechnol, 1999, 10(): 448-453. doi: 10.1016/S0958-1669(99)00008-7
-
Follenzi A, Battaglia M, Lombardo A. Targeting lentiviral vector expression to hepatocytes limits transgene-specific immune response and establishes longterm expression of human antihemophilic factor IX in mice[J]. Blood, 2004, 103(): 3700-3709. doi: 10.1182/blood-2003-09-3217
-
Follenzi A, Gupta S. The promise of lentiviral gene therapy for liver cancer[J]. J Hepatol, 2004, 40(): 337-240. doi: 10.1016/j.jhep.2003.11.023
-
Friedmann T, Roblin R. Gene therapy for human genetic disease[J]. Science, 1972, 175(): 949-955. doi: 10.1126/science.175.4025.949
-
Gruber A, Kan-Mitchell J, Kuhen K L. Dendritic cells transduced by multiply deleted HIV-1 vectors exhibit normal phenotypes and functions and elicit an HIV-specific cytotoxic T-lymphocyte response in vitro[J]. Blood, 2000, 96(): 1327-1333.
-
Ikeda Y, Taceuchi Y, Martin F. Continuous high-titer HIV-1 vector production[J]. Nat Biotechnol, 2003, 21(): 569-572. doi: 10.1038/nbt815
-
Kappes J C, Wu X. Safety consideration in vector development[J]. Somat Cell Mol Genet, 2003, 26(): 147-158.
-
Kay M A, Glorioso J C, Naldini L. Viral vectors for gene therapy: the art of tuning infectious agents into vehicles of therapeutics[J]. Nat Med, 2001, 7(): 33-40. doi: 10.1038/83324
-
Klimatcheva E, Planelles V, Day S L. Defective lentiviral vectors are efficiently trafficked by HIV-1 and inhibit its replication[J]. Mol Ther, 2001, 3(): 928-939. doi: 10.1006/mthe.2001.0344
-
Kootstra N A, Verma I M. Gene therapy with viral vectors[J]. Annu Rev Pharmacol Toxicol, 2003, 43(): 413-439. doi: 10.1146/annurev.pharmtox.43.100901.140257
-
Kwon Y J, Hung G, Anderson W F. Determination of infectious retrovirus concentration from colony-forming assay with quantitative analysis[J]. J Virol, 2003, 77(): 5712-5720. doi: 10.1128/JVI.77.10.5712-5720.2003
-
Lu Y, Liu C, Zeng L. Effficient gene transfer into human monocytes-derived macrophages using defective lentiviral vectors[J]. Cell Mol Biol, 2003, 49(): 1151-1156.
-
Ma Y, Ramizane A, Lewis R. High-level sustained transgene expression in human embryonic stem cells using lentiviral vectors[J]. Stem Cells, 2003, 21(): 111-117. doi: 10.1634/stemcells.21-1-111
-
Mautino M R. Lentiviral vectors for gene therapy of HIV-1 infection[J]. Curr Gene Ther, 2002, 2(): 3-43.
-
Miyoshi H, Blomer U, Takahashi M. Development of a self-inactivating lentiviral vector[J]. J Virol, 1998, 72(): 8150-5157.
-
Naldini L, Blomer U, Gallay P. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector[J]. Science, 1996, 272(): 263-267. doi: 10.1126/science.272.5259.263
-
Neil S, Martin F, Ikeda Y. Postentry restriction to human immunodeficiency virus-based vector transduction in human monocytes[J]. J Virol, 2001, 75(): 5448-5456. doi: 10.1128/JVI.75.12.5448-5456.2001
-
Nobel G J. Genetic, cellular and immune approaches to disease therapy: past and future[J]. Nat Med, 2004, 10(): 135-141. doi: 10.1038/nm990
-
Poznansky M, Lever A, Bergeron L. Gene transfer into human lymphocytes by a defective human immunodeficiency virus type 1 vetcor[J]. J Virol, 1991, 65(): 532-536.
-
Reiser J. Production and concentration of pseudotyped HIV-1-based gene transfer vectors[J]. Gene Ther, 2000, 7(): 910-913. doi: 10.1038/sj.gt.3301188
-
Schroers R, Sinha I, Segall H. Transduction of human PBMC-derived dendritic cells and macrophages by an HIV-1-based lentiviral vector system[J]. Mol Ther, 2000, 1(): 171-179. doi: 10.1006/mthe.2000.0027
-
Sharma S, Cantwell M, Kipps T J. Effect infectious of a human T-cell line and of human primary peripheral blood leukocytes with a pseudotyped retrovirus vector[J]. Proc Natl Acad Sci USA, 1996, 93(): 11842-11847. doi: 10.1073/pnas.93.21.11842
-
Sutton R E, Wu H T M, Rigg R. Human immunodeficiency virus type 1 vectors efficiently transduced human hematopoietic stem cells[J]. J Virol, 1998, 72(): 5781-5788.
-
Tendeloo V F I V, Broeckhoven C V, Berneman Z N. Gene therapy: principles and applications to hematopoietic cells[J]. Leukemia, 2001, 15(): 523-544.
-
Verma I M, Somia N. Gene therapy-promises, problems and prospects[J]. Nature, 1997, 389(): 239-242. doi: 10.1038/38410
-
White S M, Renda M, Nam N Y. Lentivirus vectors using human and simian immunodeficiency virus elements[J]. J Virol, 1999, 73(): 2832-2840.
-
Wong L F, Azzouz M, Walmsley L E. Transduction patterns of pseudotyped lentiviral vectors in the nervous system[J]. Mol Ther, 2004, 9(): 101-111.
-
Yee J K, Friedmann T, Burns J C. Generation of high-titer pseudotyped retroviral vector with very broad host range[J]. Methods Cell Biol, 1994, 43(): 99-112. doi: 10.1016/S0091-679X(08)60600-7
-
Zaia J A. Problems and solutions to successful gene-transfer based therapies for HIV[J]. Clin Appl Immu Rev, 2003, 10(): 1-13.
-
Zhang Y, Lu H, Liwang P. Optimization of gene expression in nonactivated circulating lymphocytes[J]. Mol Ther, 2003, 8(): 629-636. doi: 10.1016/S1525-0016(03)00231-4
-
Zufferey R, Dull T, Mandel R J. Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery[J]. J Virol, 1998, 72(): 9873-9880.